The Effect of Exenatide on Thyroid-Stimulating Hormone and Thyroid Volume

Muhammed Erkam Sencar, Murat Çalapkulu, Sema Hepşen, Ilknur Unsal Ozturk, Bekir Uçan, Murat Bayram, Mustafa Özbek, Erman Çakal

European Thyroid Journal · 2019 · 26 citations · 22 references

DOIFull text

Open access

Concepts

Abstract

OBJECTIVE: Glucagon-like peptide-1 (GLP-1) analogues are now widely used for the treatment of type 2 diabetes mellitus (DM). Many binding sites for GLP-1 have been demonstrated in the specific tissue compartments of organs in-cluding the brain and thyroid. The aim of this study was to investigate the effect of exenatide treatment on thyroid-stimulating hormone (TSH) and thyroid volume in diabetic patients without thyroid disease. MATERIAL AND METHODS: The study included 46 diabetic patients without thyroid disease who were receiving exenatide treatment. Comparisons were made of total thyroid volume and serum concentrations of TSH at baseline and after 6 months of follow-up. RESULTS: > 0.05). CONCLUSIONS: Exenatide treatment for 6 months significantly decreased serum TSH concentration but did not affect thyroid volume in diabetic patients without thyroid disease.

References

22